CanniMed Therapeutics Inc. and PharmaChoice Enter into Canada’s First Exclusive Pharmacy Distribution Agreement for Medical Cannabis

CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed”) and PharmaChoice today signed a letter of intent to collaborate on pharmacist education and the distribution, sale and marketing of medical cannabis products.

This industry-leading collaboration will see CanniMed responsible for producing and delivering accredited pharmacy education programs to PharmaChoice pharmacists and pharmacy technicians across Canada. In addition, CanniMed and PharmaChoice intend to enter a definitive agreement for distribution of medical cannabis through PharmaChoice pharmacists in Canada upon completion of the first provincial legislation change that allows such distribution.

“We are pleased that PharmaChoice recognizes the value of CanniMed’s core focus on professional education, our ability to produce standardized medical cannabis products in compliance with the government’s Good Manufacturing Practice standards, and our manufacturing capabilities to provide reliably safe products for our patients,” said Brent Zettl, President and CEO of CanniMed. “We believe that our industry is at the cusp of an important shift that...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: